Commit To Purchase BioCryst Pharmaceuticals At $2, Earn 18.6% Annualized Using Options

Investors considering a purchase of BioCryst Pharmaceuticals, Inc. (BCRX) shares, but cautious about paying the going market price of $3.35/share, might benefit from considering selling puts among the alternative strategies at their disposal..
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.